Email the editor

Newcastle draws on history for £1.1m conference boost

European Thyroid Association heads to Tyneside in 2018 thanks to city's conference ambassador programme
10/03/2016

Pictured: Newcastle Quayside and Sage Gateshead

Newcastle is set for a £1.1m boost after sealing the international European Thyroid Association (ETA) in September 2018.

The event was secured on the back of the destination’s strengths in science and healthcare - as well as its historic links to the development of thyroid hormone replacement therapy, in addition to its ambassador programme.

As well as the ETA conference, which will see 900 delegates from across Europe arrive on Tyneside for a five day conference at Sage Gateshead, the British Thyroid Association is also set to hold its 64th annual meeting at Newcastle’s Centre for Life in May 2016. 

Simon Pearce, professor of endocrinology at Newcastle University, said: "Due to Newcastle's history and excellence in medical research and through the support the NewcastleGateshead Conference Ambassador Programme we were able to bid for and win both the British and European Thyroid Associations. We look forward to welcoming delegates from both associations to the city."

Paul Szomoru, head of business tourism at NewcastleGateshead Convention Bureau, said: “We are delighted to be hosting both the British and European Thyroid Associations. NewcastleGateshead is internationally renowned for life sciences, healthcare and sustainability. We’re proud of our history and the industry leading research which is happening today in our city. Through our Conference Ambassador Programme we were able to support Simon in bidding for and bringing both of these significant events to the destination.”

The British Thyroid Association’s special commemorative meeting marks the 125th anniversary of the discovery of thyroid hormone replacement therapy.  

Newcastle is one of six designated UK Science Cities. The destination is recognised for its strengths in ageing, biomedicine and clinical trials as well as having an extensive pharmaceutical cluster, accounting for one third of the UK’s turnover in pharmaceuticals. Newcastle hospitals also undertook the UK’s largest number of clinical trials in 2015.


Facebook Share Twitter Share LinkeIn Share